Leila Burch
Physician Assistant · Flower Mound, TXNPI 1255605853
Payments from drug & device makers
Across 200 payments — averaging $24.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$684
- Takeda Pharmaceuticals U.S.A., Inc.$359
- GSK$281
- Sanofi$255
- Sanofi-aventis U.S. LLC$229
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,62993%
- Education$3587%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 33 | $1,184 |
| Regeneron Healthcare Solutions, Inc. | 40 | $684 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $359 |
| GSK | 17 | $281 |
| Sanofi | 11 | $255 |
| Sanofi-aventis U.S. LLC | 3 | $229 |
| Grifols USA, LLC | 11 | $225 |
| LEO Pharma Inc. | 3 | $222 |
| Alk-abello, Inc | 17 | $218 |
| Blueprint Medicines Corporation | 4 | $194 |
| AbbVie | 4 | $189 |
| Organon | 5 | $188 |
| Novartis | 7 | $153 |
| CSL Behring | 2 | $136 |
| Amgen | 6 | $119 |
| Genentech USA, Inc. | 4 | $47 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $39 |
| Optinose US, Inc. | 2 | $39 |
| Pfizer | 2 | $37 |
| Galderma Laboratories, L.p. | 2 | $35 |
| Lilly USA, LLC | 1 | $31 |
| Kaleo, Inc. | 2 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Covis Pharma GmbH | 1 | $19 |
| Kedrion Biopharma, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,987 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CuvitruImmun Glob G(Igg)/Gly/Iga Ov50 | 13 | $84,844 |
| Dupixent PenDupilumab | 20 | $82,423 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $15,368 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $2,052 |
| Ipratropium Bromide | 42 | $995 |
| Prednisone | 12 | $13 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Cuvitru | $359 | $84,84413 claims |
| GSKTrelegy Ellipta | $281 | $15,36826 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Flower Mound
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.